Calendar Arcutis Biotherapeutics, Inc.

Equities

ARQT

US03969K1088

Market Closed - Nasdaq 21:00:00 23/07/2024 BST 5-day change 1st Jan Change
10.20 USD +3.55% Intraday chart for Arcutis Biotherapeutics, Inc. -4.40% +215.79%

Chart calendar Arcutis Biotherapeutics, Inc.

173f02a73.KDsgH3r0J1X6n_8Sj3gkZRjU460Gdjfg-JkbWd7EcY4.f2pQUgmME22r9IZ67hkVE0mCj8c0E2Grm9V4EomMCbhDUBd3OYdNO5D9kA~edcaa1eb4aaa702cd8ef39c3897e875b

Upcoming events on Arcutis Biotherapeutics, Inc.

29/07/2024 13:30 Investor Meeting - Key Opinion Leader
31/07/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
03/03/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Arcutis Biotherapeutics, Inc.

14/06/2024 16:30 Annual General Meeting
12/06/2024 18:20 Goldman Sachs Global Healthcare Conference
10/06/2024 19:30 Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Abstract Number: 634
09/06/2024 00:00 Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 639
09/06/2024 00:00 Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 641
09/06/2024 00:00 Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference - Poster Number: 640
14/05/2024 21:30 Q1 2024 Earnings Call
14/05/2024 21:00 Q1 2024 Earnings Release
11/04/2024 19:15 Needham Healthcare Conference
10/03/2024 21:30 American Academy of Dermatology Meeting
09/03/2024 23:25 American Academy of Dermatology Meeting
04/03/2024 19:10 TD Cowen Health Care Conference
27/02/2024 13:30 Q4 2023 Earnings Call
27/02/2024 10:50 Q4 2023 Earnings Release
07/02/2024 15:00 Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat
22/01/2024 21:30 ZORYVE® FDA Approval Call
11/01/2024 Winter Clinical Dermatology Conference
18/12/2023 13:30 Roflumilast Foam FDA Approval Call
07/11/2023 14:50 Guggenheim Securities Inflammation & Immunology Conference
03/11/2023 12:30 Q3 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
3,69
2,88
27.9%
59,6
57,5
3.73%

164


247


400

EBITDA
Million USD
Released
Forecast
Spread
-206
-205
-0.34%
-301
-309
2.74%
-240
-249
3.6%

-173


-136


-50,4

EBIT
Million USD
Released
Forecast
Spread
-207
-211
1.92%
-302
-315
4.14%
-241
-249
3.01%

-175


-126


-21,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-206
-215
4.23%
-311
-327
4.73%
-259
-265
2.27%

-190


-139


-9,85

Net income
Million USD
Released
Forecast
Spread
-206
-215
4.23%
-311
-327
4.73%
-262
-267
1.93%

-191


-139


-9,85

EPS
USD
Released
Forecast
Spread
-4,18
-4,36
4.18%
-5,66
-5,96
4.98%
-3,78
-3,94
4.12%

-1,70


-1,16


-0,05

Announcement Date22/02/2228/02/2327/02/24-

Quarterly results

Fiscal PeriodMarch 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,73
0,66
9.85%
2,96
2,05
44.74%
2,78
3,11
-10.7%
5,19
4,62
12.42%
38,1
30,8
23.65%
13,5
11,4
18.77%
49,6
15,1
227.4%

29,1


36,8


45,1


55,0


63,0


71,0


71,0

EBITDA
Million USD
Released
Forecast
Spread



-105
-101
-3.66%
-68,3
-77,3
11.69%
-76,1
-73,0
-4.23%
-66,6


-36,7
-46,0
20.21%



























EBIT
Million USD
Released
Forecast
Spread
-65,8
-72,2
8.88%
-105
-102
-3.05%
-68,4
-82,4
17%
-76,3
-72,8
-4.75%
-66,8
-72,9
8.47%
-36,9
-49,3
25.16%
-61,2
-67,3
9.16%
-31,6
-62,5
49.38%

-53,0


-47,3


-42,9


-35,4


-31,6


-27,7


-30,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-67,4
-74,0
8.91%
-108
-111
3.34%
-72,0
-88,1
18.29%
-80,1
-76,6
-4.62%
-71,0
-76,4
7.08%
-41,7
-55,6
24.88%
-66,3
-72,3
8.4%
-35,1
-67,3
47.91%

-56,9


-50,9


-48,2


-35,4


-31,6


-27,7


-30,3

Net income
Million USD
Released
Forecast
Spread
-67,4
-74,0
8.91%
-108
-104
-3.47%
-72,0
-88,1
18.29%
-80,1
-76,6
-4.62%
-71,0
-76,4
7.08%
-44,8
-55,6
19.44%
-66,3
-71,3
7.04%
-35,4
-67,3
47.43%

-56,9


-50,9


-48,0


-35,4


-31,6


-27,7


-30,3

EPS
USD
Released
Forecast
Spread
-1,31
-1,43
8.39%
-1,89
-1,88
-0.35%
-1,18
-1,45
18.43%
-1,31
-1,25
-4.52%
-1,16
-1,24
6.45%
-0,73
-0,88
16.57%
-0,72
-0,79
8.57%
-0,32
-0,73
56.16%

-0,51


-0,47


-0,43


-0,30


-0,30


-0,25


-0,25

Announcement Date04/08/2208/11/2228/02/2309/05/2308/08/2303/11/2327/02/2414/05/24-------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARQT Stock
  4. Calendar Arcutis Biotherapeutics, Inc.